Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response

被引:89
作者
Lewis, PJ [1 ]
Littel-van den Hurk, SV [1 ]
Babiuk, LA [1 ]
机构
[1] Univ Saskatchewan, Vet Infect Dis Org, Saskatoon, SK S7N 5E3, Canada
关键词
D O I
10.1128/JVI.73.12.10214-10223.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The potential for DNA vaccines encoding mutated versions of the same antigen to modulate immune responses in C3H/HeN mice was investigated. We created expression plasmids that encoded several versions of glycoprotein D (gD) from bovine herpesvirus 1, including authentic membrane-anchored glycoprotein (pSLRSV.AgD), a secreted glycoprotein (pSLRSV.SgD), and an intracellular protein (pSLRSV.CgD). Immunization of an inbred strain of mice with these plasmids resulted in highly efficacious and long-lasting humoral and cell-mediated immunity. We also demonstrated that the cell compartment in which plasmid-encoded go was expressed caused a deviation in the serum immunoglobulin (Ig) isotype profile as well as the predominant cytokines secreted from the draining lymph node. Immunization of C3H/HeN mice with DNA vaccines encoding cell-associated forms of go resulted in a predominance of serum IgG2a and gamma interferon-secreting cells within the spleens and draining lymph nodes. In contrast, mice immunized with a secreted form of this same antigen displayed immune responses characterized by greater levels of interleukin 4 in the draining lymph node and IgG1 as the predominant serum isotype. We also showed evidence of compartmentalization of distinct immune responses within different lymphoid organs.
引用
收藏
页码:10214 / 10223
页数:10
相关论文
共 87 条
[1]   Interferon-gamma inductive effect of liposomes as an immunoadjuvant [J].
Aramaki, Y ;
Suda, H ;
Tsuchiya, S .
VACCINE, 1995, 13 (18) :1809-1814
[2]   ADJUVANTS - CURRENT STATUS, CLINICAL PERSPECTIVES AND FUTURE-PROSPECTS (REPRINTED FROM TRENDS IN PHARMACOLOGICAL SCIENCES, VOL 14, PG 174-178, 1993) [J].
AUDIBERT, FM ;
LISE, LD .
IMMUNOLOGY TODAY, 1993, 14 (06) :281-284
[3]   DEFENSE-MECHANISMS AGAINST BOVINE HERPESVIRUS - RELATIONSHIP OF VIRUS-HOST CELL EVENTS TO SUSCEPTIBILITY TO ANTIBODY-COMPLEMENT CELL LYSIS [J].
BABIUK, LA ;
WARDLEY, RC ;
ROUSE, BT .
INFECTION AND IMMUNITY, 1975, 12 (05) :958-963
[4]   PROTECTION OF CATTLE FROM BOVINE HERPESVIRUS TYPE-I (BHV-1) INFECTION BY IMMUNIZATION WITH INDIVIDUAL VIRAL GLYCOPROTEINS [J].
BABIUK, LA ;
LITALIEN, J ;
LITTELVANDENHURK, SV ;
ZAMB, T ;
LAWMAN, MJP ;
HUGHES, G ;
GIFFORD, GA .
VIROLOGY, 1987, 159 (01) :57-66
[5]   Immunogenicity of bovine herpesvirus 1 glycoprotein D in mice: Effect of antigen form on the induction of cellular and humoral immune responses [J].
BacaEstrada, ME ;
Snider, M ;
Tikoo, SK ;
Harland, R ;
Babiuk, LA ;
LittelVandenHurk, SV .
VIRAL IMMUNOLOGY, 1996, 9 (01) :11-22
[6]   REGULATION OF IGG ANTIBODY-TITERS BY THE AMOUNT OF PERSISTING IMMUNE-COMPLEXED ANTIGEN [J].
BACHMANN, MF ;
KUNDIG, TM ;
HENGARTNER, H ;
ZINKERNAGEL, RM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (10) :2567-2570
[7]   The role of antibody concentration and avidity in antiviral protection [J].
Bachmann, MF ;
Kalinke, U ;
Althage, A ;
Freer, G ;
Burkhart, C ;
Roost, HP ;
Aguet, M ;
Hengartner, H ;
Zinkernagel, RM .
SCIENCE, 1997, 276 (5321) :2024-2027
[8]   Induction of long-lived germinal centers associated with persisting antigen after viral infection [J].
Bachmann, MF ;
Odermatt, B ;
Hengartner, H ;
Zinkernagel, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (05) :2259-2269
[9]  
BOHLFELD R, 1994, IMMUNOL TODAY, V15, P269
[10]   THE SKIN IMMUNE-SYSTEM - PROGRESS IN CUTANEOUS BIOLOGY [J].
BOS, JD ;
KAPSENBERG, ML .
IMMUNOLOGY TODAY, 1993, 14 (02) :75-78